Physician profile
Thomas Selvaggi
NPI 1083664197
$11,604.58
in general payments reported to CMS, 2019-2025
9 companies · $58.60 in 2025
The $58.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.38 · 2020: $1,577 · 2021: $1,594 · 2022: $2,595 · 2023: $5,712 · 2025: $58.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,635 · Food and Beverage: $678 · Travel and Lodging: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,635.00 |
| Food and Beverage | $677.71 |
| Travel and Lodging | $458.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11,251.06 | 2020-2023 | |
| Abbvie INC. | $170.70 | 2020-2023 | Vraylar |
| Regeneron Healthcare Solutions, INC. | $38.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $36.05 | 2025 | Austedo Xr |
| Csl Behring | $35.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.80 | 2019 | |
| Allergan, INC. | $20.30 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $17.95 | 2025 | Neffy |
| Organon LLC | $4.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Selvaggi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.